Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single‐Chain Antibody Specific for Activated GPIIb/IIIa

Authors

Keywords

Journal

Volume 6, Issue 2, Pages e004535

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2017-02-04

DOI

10.1161/jaha.116.004535

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now